Immunovant, Inc. (IMVT)
27.05
+2.99
(+12.43%)
USD |
NASDAQ |
Feb 06, 16:00
26.98
-0.07
(-0.26%)
Pre-Market: 08:20
Immunovant SG&A Expense (TTM) : 79.15M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Boston Scientific Corp. | 6.888B |
| Revvity, Inc. | 991.89M |
| Viridian Therapeutics, Inc. | 77.23M |
| Plus Therapeutics, Inc. | 11.09M |
| Nutriband, Inc. | 7.831M |